We are pleased to confirm the participation of the following international speakers.
Deverick (“Dev”) J. Anderson, MD, MPH, FIDSA, FSHEA
Dr. Anderson is an Associate Professor in the Division of Infectious Diseases and Department of Medicine at Duke University. He is currently Director of the Duke Center for Antimicrobial Stewardship and Infection Prevention. Over the past decade, Dr. Anderson’s work has led to improvements in the quality and safety of care in multiple areas of healthcare, including large tertiary care hospitals and small community hospitals.
Dr. Anderson has authored over 140 peer-reviewed articles related to quality of care, patient safety, healthcare epidemiology, antimicrobial stewardship, and multidrug-resistant pathogens. Dr. Anderson has received research funding from the NIH, the AHRQ, and the CDC and is currently the Principal Investigator of the Duke-UNC Prevention Epicenter Program. He is a member of the Board of Trustees for SHEA. In addition, he is an alumnus of the Robert Wood Johnson Foundation Physician Faculty Scholars Program and a member of the Steering Committee for the NIH’s Antibacterial Resistance Leadership Group.
Susan Huang, MD MPH is Professor of Medicine in the Division of Infectious Diseases and Medical Director of Epidemiology and Infection Prevention at the University of California Irvine.
She received her MD from Johns Hopkins and her MPH from the Harvard School of Public Health. She completed residency at the University of California San Francisco and her ID fellowship at Harvard at Brigham & Women’s Hospital and Massachusetts General Hospital.
Dr. Huang has over 130 publications and is lead investigator of five randomized clinical trials on preventing HAIs and drug-resistant pathogens in hospitals and nursing homes. Her research includes efforts toward surgical site infections, outbreak detection, and regional simulation models to prevent contagious spread.
Dr. Huang has served on the US CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC), the Antibiotic Resistance Committee for the Infectious Diseases Society of America, and the Clinical Effectiveness Research Innovation Collaborative of the US National Academies of Medicine.